Western Bloting: 1/500 - 1/2000. Immunohistochemistry: 1/200 - 1/1000. ELISA: Propose dilution 1/10000. Not yet tested in other applications. Determining optimal working dilutions by titration test.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C
Ishii, Yoshida, Akechi, Sakabe, Nishio, Ikeda, Terabayashi, Matsumi, Gonda, Okamoto, Takubo, Tajima, Tsuchiya, Hoshikawa, Kurimasa, Umezawa, Shiota: "Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta." in: Hepatology (Baltimore, Md.), Vol. 48, Issue 2, pp. 597-606, (2008) (PubMed).
Halmos, Bassères, Monti, DAló, Dayaram, Ferenczi, Wouters, Huettner, Golub, Tenen: "A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer." in: Cancer research, Vol. 64, Issue 12, pp. 4137-47, (2004) (PubMed).
FOXA2 (forkhead box A2), also known as HNF3B (hepatocyte nuclear factor 3, beta). It is a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. FOXA2 has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for FOXA2. Synonyms: HNF3B, TCF3B, MGC19807